top of page
BrainTalk
Software for Detecting Cognitive Deficits
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
BrainTalk | NeuroPharmacology | NeuroBioTechnology | Digital & Health care | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Other | 01/01/2016 | "1-10" |
BrainTalk is a software solution that detects cognitive deficits quickly and accurately based on a five-minute speech sample. BrainTalk has a patent-pending intelligent algorithm that can detect cognitive deficits from stroke, aging, disease, and medical interventions such as chemotherapy.
BrainTalk’s technology is designed to give health and sports organizations a noninvasive, cost-effective, and repeatable tool to screen and monitor large populations with known or suspected brain damage.
BrainTalk is the product of a collaboration between Israel’s National Institute for the Rehabilitation of the Brain Injured and the U.S.-based predictive analytics company SentiMetrix.
bottom of page